Model N to Acquire Deloitte’s Life Sciences Pricing and Contracting Solutions Business

Revenue Management Market Leader Expands Market Opportunity with Acquisition

Model N, the leader in cloud revenue management solutions, announced that it has entered into a definitive agreement to acquire Deloitte’s life sciences pricing and contracting solutions business and underlying technology.

Read More: DocuSign Welcomes Healthcare And Financial Services Exec Cain Hayes To Board

“We are very excited to welcome Deloitte’s life sciences pricing and contracting solutions customers and employees to the Model N community. We believe the acquisition of this business allows us to offer revenue management to the broader life sciences market”

The acquisition broadens Model N’s portfolio to better serve a larger segment of the market from pre-commercial to the largest life sciences companies in the world. It also brings new life sciences customers, talent and intellectual property that complement Model N’s robust customer base and market leading offering.

Read More: Suplari Launches Diversity Insights: Using AI To Help Companies Meet Supplier Diversity Goals

“We are very excited to welcome Deloitte’s life sciences pricing and contracting solutions customers and employees to the Model N community. We believe the acquisition of this business allows us to offer revenue management to the broader life sciences market,” said Jason Blessing, president and chief executive officer of Model N. “Deloitte’s cloud software and expert services solution are purpose built to help companies scale from pre-commercial to billion dollar enterprises. Model N has not historically gone after the pre-commercial segment so this is an exciting addition to our total addressable market.”

Model N plans to acquire Deloitte’s life sciences pricing and contracting solutions business and underlying technology for $60 million in cash. Model N expects the transaction to close in late December 2020 and to have no contribution to its first quarter fiscal year 2021 results. More financial details of the transaction will be provided on Model N’s first quarter fiscal year 2021 earnings conference call after the transaction has closed.

Write in to psen@itechseries.com to learn more about our exclusive editorial packages and programs.

contracting solutionsDeloittelife sciences pricingModel NNewsRevenue ManagementTechnology
Comments (0)
Add Comment